Stockadora

8-K filings / November 20, 2026

RenovoRx, Inc.: A change of officers or directors

RenovoRx, Inc. filed a current report (Form 8-K) with the SEC on November 20, 2026. It reports a change of officers or directors.

Item 5.02

Officers and directors

  • Appointed Richard Stark, DirectorEffective November 18, 2026 From the filing
    Source
    “Effective as of November 18, 2026, the Board of Directors (the “Board”) of RenovoRx, Inc., a Delaware corporation (the “Company”), approved an increase the size of the Board from six directors to seven directors and appointed Richard Stark to fill the vacancy on the Board occasioned by such increase (the “Appointment”).”
    Read by code from this sentence of the filing.
Not investment advice.Read the filing on SEC.gov

Facts read from the filing's own text; a fact the filing does not state clearly is left out. All documents of this filing on SEC.gov.